Biogen
1924 articles about Biogen
-
Biogen Idec, Inc. (Massachusetts) Gains Rights to Acorda Therapeutics's MS Drug; Acorda to Get $110 Million Up Front
7/1/2009
-
Biogen Idec, Inc. (Massachusetts) (JOBS) Reports 10th Case of PML Brain Infection in Patient Taking Tysabri
6/30/2009
-
Biogen Idec, Inc. (Massachusetts) and Fellow Boston-Area Biotechs Ready for Biogenerics
6/24/2009
-
Biogen Idec, Inc. (Massachusetts) Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
6/22/2009
-
Biogen Idec, Inc. (Massachusetts) Announces First Patient Enrolled in the Global Phase III Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis
6/22/2009
-
Biogen Idec, Inc. (Massachusetts) Announces Conclusion of Arbitration with Genentech, Inc.
6/17/2009
-
Biogen Idec, Inc. (Massachusetts) to Present at the Goldman Sachs 30th Annual Healthcare Conference
6/9/2009
-
Biogen Idec, Inc. (Massachusetts) And Elan Corporation PLC Release: MS Patients Report Greater Treatment Satisfaction with TYSABRI
6/9/2009
-
Biogen Idec, Inc. (Massachusetts) Announces Preliminary Results of Stockholder Vote
6/4/2009
-
Biogen Idec, Inc. (Massachusetts) Sends Letter to Stockholders
5/27/2009
-
Biogen Idec, Inc. (Massachusetts) Joins with the Global MS Community to Mark World MS Day
5/27/2009
-
Biogen Idec, Inc. (Massachusetts) Comments on Proxy Advisory Firms' Reports
5/26/2009
-
Icahn Says Biogen Idec, Inc. (Massachusetts) Should Weigh Splitting in Two
5/12/2009
-
Elan Corporation PLC's Tysabri May Reverse MS Damage, Shares Up
4/29/2009
-
Biogen Idec, Inc. (Massachusetts) Board Recommends Shareholders Elect Directors with Record of Success in Enhancing the Value of the Company
4/28/2009
-
Biogen Idec, Inc. (Massachusetts) Reports 6th Case of PML in Tysabri Patients
4/20/2009
-
ION Labs Inc. Recalls Influend Cough and Cold Products, in Alabama, Because Of Possible Health Risk
4/17/2009
-
Biogen Idec, Inc. (Massachusetts) 1st-Quarter Earnings Up But Sales Disappoint
4/17/2009
-
Biogen Idec, Inc. (Massachusetts) Receives FDA Approval for TYSABRI High Titer Production
4/16/2009
-
Biogen Idec, Inc. (Massachusetts) Showcases Leading Multiple Sclerosis Franchise and Pipeline at the 61st Annual Meeting of the American Academy of Neurology
4/15/2009